Investigating the Role of Reduced Branched-Chain Amino Acid Catabolism in Clear Cell Renal Cell Carcinoma

研究支链氨基酸分解代谢减少在透明细胞肾细胞癌中的作用

基本信息

  • 批准号:
    10464235
  • 负责人:
  • 金额:
    $ 5.18万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-07-01 至 2025-06-30
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY North America has the highest incidence of renal cancer in the world with the most common subtype being clear cell renal cell carcinoma (ccRCC). Alarmingly, the incidence of ccRCC is on the rise in the U.S. and globally. The overall five-year survival rate for ccRCC is only 10-12% once it becomes metastatic, demonstrating the need for new therapies. Metabolic dysfunction is common in ccRCC based on histologic and molecular analysis. New therapies to treat ccRCC could target its dysregulated metabolic pathways. The etiology of ccRCC is complex but a major risk factor is obesity. High levels of branched-chain amino acids (BCAAs) are present in the serum of patients with ccRCC and obesity, suggesting a potential mechanistic link. BCAAs (leucine, isoleucine, and valine) are essential amino acids, whose concentrations are regulated by dietary intake and catabolism. BCAA metabolism promotes tumor growth in many different types of cancer, but the role of BCAAs in ccRCC is unknown. BCAA catabolism occurs primarily via the first two enzymes, BCAA transaminase (BCAT) and branched chain ketoacid dehydrogenase (BCKDH), respectively. BCKDH is an enzyme complex that catalyzes the rate-limiting reaction. The products of BCAA catabolism are then oxidized within the mitochondria to produce succinyl-CoA and acetyl-CoA, which can be used by the TCA cycle for anaplerosis and mitochondrial respiration. My preliminary data demonstrate that BCAA catabolic enzyme BCAT2 and BCKDH subunits are frequently reduced in human ccRCC tumors compared to normal adjacent kidney tissue (NAT). This decreased expression occurs as early as stage 1 and is associated with reduced overall survival. Additionally, BCAAs and their catabolic metabolites are decreased in ccRCC. These results suggest that BCAA catabolism is reduced early in ccRCC and contributes to ccRCC aggressiveness. ccRCC may reduce BCAA metabolism to decrease mitochondrial respiration and ROS because ccRCC is susceptible to ROS due to the large amount of intracellular lipids that can undergo peroxidation. ccRCC decreases mitochondrial respiration and ROS by downregulating genes involved in fatty acid oxidation and oxidative phosphorylation. I hypothesize that reduced BCAA metabolism promotes ccRCC cell growth and tumorigenesis, and does so by decreasing mitochondrial respiration and the production of ROS. Aim 1 will determine how reduced BCAA catabolism promotes ccRCC cell growth in vitro. I will use genetic and pharmacologic approaches to assess how gain or loss of BCAA metabolism affects proliferation of ccRCC and immortalized renal epithelial cell lines. Aim 2 will identify how reduced BCAA catabolism contributes to ccRCC tumorigenesis in vivo. I will use novel genetic mouse models to determine the role of BCAA catabolic flux on renal epithelial cell function and ccRCC tumorigenesis. Together, these approaches will identify the mechanisms by which BCAA catabolism regulates ccRCC tumorigenesis and identify novel therapeutic targets to combat this disease.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Nathan Jackson Coffey其他文献

Nathan Jackson Coffey的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Nathan Jackson Coffey', 18)}}的其他基金

Investigating the Role of Reduced Branched-Chain Amino Acid Catabolism in Clear Cell Renal Cell Carcinoma
研究支链氨基酸分解代谢减少在透明细胞肾细胞癌中的作用
  • 批准号:
    10675456
  • 财政年份:
    2022
  • 资助金额:
    $ 5.18万
  • 项目类别:

相似海外基金

The molecular basis for how acetyl-coenzyme A links metabolism to gene expression
乙酰辅酶 A 如何将代谢与基因表达联系起来的分子基础
  • 批准号:
    8783415
  • 财政年份:
    2014
  • 资助金额:
    $ 5.18万
  • 项目类别:
The molecular basis for how acetyl-coenzyme A links metabolism to gene expression
乙酰辅酶 A 如何将代谢与基因表达联系起来的分子基础
  • 批准号:
    8996048
  • 财政年份:
    2014
  • 资助金额:
    $ 5.18万
  • 项目类别:
The molecular basis for how acetyl-coenzyme A links metabolism to gene expression
乙酰辅酶 A 如何将代谢与基因表达联系起来的分子基础
  • 批准号:
    9125794
  • 财政年份:
    2014
  • 资助金额:
    $ 5.18万
  • 项目类别:
MODEL STUDIES OF ACETYL COENZYME A SYNTHASE
乙酰辅酶A合酶的模型研究
  • 批准号:
    6727647
  • 财政年份:
    2000
  • 资助金额:
    $ 5.18万
  • 项目类别:
Model Studies of Acetyl Coenzyme A Synthase
乙酰辅酶A合酶的模型研究
  • 批准号:
    7046635
  • 财政年份:
    2000
  • 资助金额:
    $ 5.18万
  • 项目类别:
MODEL STUDIES OF ACETYL COENZYME A SYNTHASE
乙酰辅酶A合酶的模型研究
  • 批准号:
    6127832
  • 财政年份:
    2000
  • 资助金额:
    $ 5.18万
  • 项目类别:
MODEL STUDIES OF ACETYL COENZYME A SYNTHASE
乙酰辅酶A合酶的模型研究
  • 批准号:
    6519988
  • 财政年份:
    2000
  • 资助金额:
    $ 5.18万
  • 项目类别:
Model Studies of Acetyl Coenzyme A Synthase
乙酰辅酶A合酶的模型研究
  • 批准号:
    7166829
  • 财政年份:
    2000
  • 资助金额:
    $ 5.18万
  • 项目类别:
Model Studies of Acetyl Coenzyme A Synthase
乙酰辅酶A合酶的模型研究
  • 批准号:
    7544968
  • 财政年份:
    2000
  • 资助金额:
    $ 5.18万
  • 项目类别:
MODEL STUDIES OF ACETYL COENZYME A SYNTHASE
乙酰辅酶A合酶的模型研究
  • 批准号:
    6386442
  • 财政年份:
    2000
  • 资助金额:
    $ 5.18万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了